Cerevasc’s eShunt system receives US FDA Breakthrough Device designation for use in paediatric patients
Cerevasc announced recently that it has received its second Breakthrough Device designation from the US Food and Drug Administration (FDA) for its investigational eShunt...
New clinical studies demonstrate reliable volume and midline shift estimation with Viz ICH Plus
Viz.ai has announced new clinical data validating the accuracy and clinical utility of its artificial intelligence (AI)-powered hyperdensity measurement solution for intracranial haemorrhage (ICH)...
Perfuze completes enrolment in pivotal US study, appoints new executive vice president of sales
Perfuze has announced two “significant milestones” in its mission to improve stroke care: the completion of patient enrolment in its US pivotal investigational device...
CX responds: Carotid endarterectomy maintains its golden hue
The established ‘gold standard’ approach to carotid revascularisation remained enshrined as the go-to operation as far as the Charing Cross (CX; 23–25 April, London,...
